Enhancements    

SC2: PACLITAXEL DIRECTED DRUG SCREENING: A NEW STRATEGY TO IDENTIFY ANTI-CANCER DRUGS

SC2: PACLITAXEL DIRECTED DRUG SCREENING: A NEW STRATEGY TO IDENTIFY ANTI-CANCER DRUGS
PI: Giulio Francia
Sponsor: NIH - NATIONAL CANCER INSTITUTE
Biological Sciences
Amount awarded: $453,000

This project will identify compounds that can improve the efficacy of clinically used chemotherapy, which should ultimately lead to an increase in the overall survival for those breast cancer patients receiving paclitaxel based therapies.Our hypothesis is that drugs that inhibit the recovery of breast cancer cells exposed to paclitaxel are ideally suited for maximizing the anti-cancer benefit of this chemotherapy.

Posting date: Fri, 09/23/2016

Award start date:
Award end date: